Mouse study: adipose FGF21 signalling links protein restriction to anti-senescence effects
In genetic loss-of-function mouse models, FGF21–KLB signalling in fat cells was reported as indispensable for the anti-senescence effects of dietary protein restriction, preserving mitochondrial integrity, an anti-inflammatory milieu and NAD homeostasis. [1]
Automatic summary · not editorially reviewed
The key findings
In genetic loss-of-function mouse models, FGF21–KLB signalling in adipocytes was reported as indispensable for the anti-senescence effects of dietary protein restriction. [1]
Adipocyte FGF21 signalling is described as preserving mitochondrial integrity, an anti-inflammatory milieu and NAD homeostasis under protein restriction. [1]
High-protein feeding is reported to induce adipocyte senescence and metabolic dysfunction, which exogenous FGF21 supplementation could mitigate. [1]
The source at a glance
- Study type / format
- Preclinical mouse study (abstract)
- Population / context
- Mice in genetic loss-of-function models for FGF21 and β-Klotho, studied under dietary protein restriction and high-protein feeding.
- Summary based on
- Study abstract
- Original publication
- August 28, 2026
Protein restriction and FGF21 in mouse loss-of-function models
The abstract describes dietary protein restriction (PR) as a nutritional intervention that improves metabolic health and extends lifespan, with mechanisms not well understood. Using genetic loss-of-function models for fibroblast growth factor 21 (FGF21) and its co-receptor β-Klotho (KLB), the authors report that FGF21–KLB signalling in adipocytes (fat cells) is indispensable for the anti-senescence effects of PR.
Supporting source [1]
Adipocyte NAD and mitochondria under protein restriction
According to the abstract, adipocyte FGF21 signalling preserves mitochondrial integrity, maintains an anti-inflammatory milieu and sustains nicotinamide adenine dinucleotide (NAD) homeostasis under PR. Mechanistically, FGF21 is said to enhance adipocyte NAD abundance through activation of AMP-activated protein kinase to maintain mitochondrial integrity. High-protein feeding is reported to induce adipocyte senescence and metabolic dysfunction, which exogenous FGF21 supplementation could mitigate.
Supporting source [1]
Preclinical scope of the adipose FGF21 findings
The authors conclude that adipose FGF21 signalling is an endocrine axis coupling dietary protein availability to adipocyte NAD metabolism and call it a promising target for prevention and treatment of age-related metabolic disorders. These are findings from genetic mouse models described in an abstract; they do not establish that targeting this pathway prevents or treats metabolic disease in humans.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. Findings come from genetic mouse models, and the abstract does not report sample sizes, follow-up or human outcomes. The proposed target for age-related metabolic disorders is not established as a human treatment.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Yang X, Wu Y, Yang Y, Huang L, Jin X, Jiang X, Jin C, Feng B, Che L, Xu S, Lin Y, Zhuo Y, Wu, Hua L. · europepmc.org · August 28, 2026